BREAKING
Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25 13 hours ago Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates 13 hours ago CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 14 hours ago VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% 14 hours ago VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 15 hours ago Townsquare Media, Inc. (TSQ) Beats Q4 EPS Estimates 15 hours ago Science Applications International (SAIC) Beats Q4 EPS Estimates 15 hours ago Bitcoin Depot Inc. (BTM) Reports Q4 Earnings 15 hours ago NXP Semiconductors (NXPI) Maintains $1.01 Quarterly Dividend, 2.13% Yield With March 25 Ex-Date 17 hours ago Methanex (MEOH) Stock Plunges 10.9% as Q4 Loss of $0.14/Share Misses Estimate by 121.7% 18 hours ago Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25 13 hours ago Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates 13 hours ago CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 14 hours ago VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% 14 hours ago VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 15 hours ago Townsquare Media, Inc. (TSQ) Beats Q4 EPS Estimates 15 hours ago Science Applications International (SAIC) Beats Q4 EPS Estimates 15 hours ago Bitcoin Depot Inc. (BTM) Reports Q4 Earnings 15 hours ago NXP Semiconductors (NXPI) Maintains $1.01 Quarterly Dividend, 2.13% Yield With March 25 Ex-Date 17 hours ago Methanex (MEOH) Stock Plunges 10.9% as Q4 Loss of $0.14/Share Misses Estimate by 121.7% 18 hours ago
ADVERTISEMENT
Market News

Rambus shares slip after Q4 revenue reaches $190.2 million

Rambus Inc. (NASDAQ: RMBS) closed at $113.71, down 0.11% on the session. Market capitalization: $12.28 billion. Latest Quarterly Results (Q4 2025) For the quarter ended December 31, 2025, Rambus reported consolidated GAAP revenue of $190.2 million and GAAP net income of $63.8 million. Product revenue for the quarter was $96.8 million. Royalty revenue was $71.6 […]

February 2, 2026 2 min read

Rambus Inc. (NASDAQ: RMBS) closed at $113.71, down 0.11% on the session. Market capitalization: $12.28 billion. Latest Quarterly Results (Q4 2025) For the quarter ended December 31, 2025, Rambus reported consolidated GAAP revenue of $190.2 million and GAAP net income of $63.8 million. Product revenue for the quarter was $96.8 million. Royalty revenue was $71.6 […]

Latest Quarterly Results (Q4 2025)

Segment Highlights:

– Product revenue (memory interface chips and related products): $96.8 million.
– Royalty revenue (patent and IP royalties): $71.6 million.
– Contract and other revenue: $21.8 million.

Financial Trends

For fiscal year 2025, Rambus reported total GAAP revenue of $707.6 million and GAAP net income of $263.4 million. Non-GAAP net income was reported at $285.0 million per company reconciliation. Cash generated from operations for fiscal 2025 was $360.0 million. Compared with fiscal 2024, the company recorded year-over-year growth in both revenue and cash from operations.

Business & Operations Update

Rambus reported record product revenue in fiscal 2025 driven by DDR5 RCD programs and expanding product lines. The company continued investment in research and development and operational scaling to support product ramps. Management highlighted ongoing qualification and customer onboarding for new memory interface chipsets, along with manufacturing and testing capacity additions to support higher volumes.

M&A or Strategic Moves

The company did not announce any acquisitions, divestitures, or material strategic transactions during the period. No definitive M&A agreements were disclosed in the earnings materials.

Equity Analyst Commentary

Institutional research summaries referenced in public analyst notes highlighted sequential product revenue growth and higher cash generation. Commentary cited the contribution from DDR5 memory interface chips and newer product categories, presented as factual summaries without recommendations or valuation targets.

Guidance & Outlook — what to watch for

What to watch for includes the company’s issued revenue guidance for the first quarter of fiscal 2026, updates to licensing billings, qualification timing for new products, capital deployment disclosures, and changes in cash generation linked to product ramps.

Performance Summary

Stock down 0.11% at close. Q4 GAAP revenue was $190.2 million, with GAAP net income of $63.8 million. Product and royalty revenues were the principal contributors. Cash from operations for fiscal 2025 was $360.0 million.

ADVERTISEMENT